BIOMAT Database Logo BIOMAT Database Logo

Increased secretion of urokinase-type plasminogen activator by human lung microvascular endothelial cells. 1998

K Takahashi, and Y Uwabe, and Y Sawasaki, and T Kiguchi, and H Nakamura, and K Kashiwabara, and H Yagyu, and T Matsuoka
Fifth Department of Internal Medicine, Tokyo Medical College, Ibaraki 300-0395, Japan.

Human lung microvascular endothelial cells (HLMECs) secreted 1.5-15 times more urokinase-type plasminogen activator (uPA) antigen than human hepatic microvascular endothelial cells, human umbilical vein endothelial cells (HUVECs), angioma endothelial cells, and lung fibroblasts. All of these cells also secreted a 100-fold greater amount of plasminogen activator inhibitor-1 than of uPA antigen, and uPA activities were not detected in the culture medium. The expression of uPA mRNA in HLMECs was higher (100-fold) compared with HUVECs, angioma endothelial cells, and lung fibroblasts. HLMECs secreted uPA antigen on both the luminal and basal sides of the cells. On the other hand, HLMECs secreted a 10- to 15-fold lower amount of tissue-type plasminogen activator than HUVECs, mostly on the luminal side. After stimulation with interleukin (IL)-1beta, HLMECs secreted a six- to ninefold amount of uPA antigen. In contrast, no stimulatory effect was observed in HUVECs even under high IL-1beta concentrations. The secretion of uPA and plasminogen activator inhibitor-1 from HLMECs was also enhanced by tumor necrosis factor-alpha and IL-2. These results suggest that HLMECs may contribute not only to the patency of lung vessels but also to the maintenance of alveolar functions through the production and secretion of uPA, especially in the presence of inflammatory cytokines.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008102 Liver Circulation The circulation of BLOOD through the LIVER. Hepatic Circulation,Circulation, Liver,Circulation, Hepatic
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D011650 Pulmonary Alveoli Small polyhedral outpouchings along the walls of the alveolar sacs, alveolar ducts and terminal bronchioles through the walls of which gas exchange between alveolar air and pulmonary capillary blood takes place. Alveoli, Pulmonary,Alveolus, Pulmonary,Pulmonary Alveolus
D011652 Pulmonary Circulation The circulation of the BLOOD through the LUNGS. Pulmonary Blood Flow,Respiratory Circulation,Circulation, Pulmonary,Circulation, Respiratory,Blood Flow, Pulmonary,Flow, Pulmonary Blood,Pulmonary Blood Flows
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums

Related Publications

K Takahashi, and Y Uwabe, and Y Sawasaki, and T Kiguchi, and H Nakamura, and K Kashiwabara, and H Yagyu, and T Matsuoka
G-CSF increases secretion of urokinase-type plasminogen activator by human lung cancer cells.
August 1998, Clinical & experimental metastasis,
K Takahashi, and Y Uwabe, and Y Sawasaki, and T Kiguchi, and H Nakamura, and K Kashiwabara, and H Yagyu, and T Matsuoka
Polarized secretion of urokinase-type plasminogen activator by epithelial cells.
November 1992, Experimental cell research,
K Takahashi, and Y Uwabe, and Y Sawasaki, and T Kiguchi, and H Nakamura, and K Kashiwabara, and H Yagyu, and T Matsuoka
Lung capillary endothelial cells produce and secrete urokinase-type plasminogen activator.
July 1992, American journal of respiratory cell and molecular biology,
K Takahashi, and Y Uwabe, and Y Sawasaki, and T Kiguchi, and H Nakamura, and K Kashiwabara, and H Yagyu, and T Matsuoka
Interleukin-4 stimulates expression of urokinase-type-plasminogen activator in cultured human foreskin microvascular endothelial cells.
June 1993, Blood,
K Takahashi, and Y Uwabe, and Y Sawasaki, and T Kiguchi, and H Nakamura, and K Kashiwabara, and H Yagyu, and T Matsuoka
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
February 1990, The Journal of biological chemistry,
K Takahashi, and Y Uwabe, and Y Sawasaki, and T Kiguchi, and H Nakamura, and K Kashiwabara, and H Yagyu, and T Matsuoka
Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells.
May 1990, Blood,
K Takahashi, and Y Uwabe, and Y Sawasaki, and T Kiguchi, and H Nakamura, and K Kashiwabara, and H Yagyu, and T Matsuoka
Tumor necrosis factor induction of urokinase-type plasminogen activator in human endothelial cells.
January 1991, Biomedica biochimica acta,
K Takahashi, and Y Uwabe, and Y Sawasaki, and T Kiguchi, and H Nakamura, and K Kashiwabara, and H Yagyu, and T Matsuoka
Borrelia burgdorferi induces secretion of pro-urokinase-type plasminogen activator by human monocytes.
October 1996, Infection and immunity,
K Takahashi, and Y Uwabe, and Y Sawasaki, and T Kiguchi, and H Nakamura, and K Kashiwabara, and H Yagyu, and T Matsuoka
Secretion of single-chain urokinase-type plasminogen activator from insect cells.
October 1991, Gene,
K Takahashi, and Y Uwabe, and Y Sawasaki, and T Kiguchi, and H Nakamura, and K Kashiwabara, and H Yagyu, and T Matsuoka
Vascular origin determines plasminogen activator expression in human endothelial cells. Renal endothelial cells produce large amounts of single chain urokinase type plasminogen activator.
February 1989, The Journal of biological chemistry,
Copied contents to your clipboard!